Xiangxue Pharmaceutical
Xiangxue Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of modern Chinese medicine in China. The company provides ban lan gen granules, flu-over liquid, juhong cough-off liquid, and juhong cough-off decoction; chinese herbal, such as huazhou citri grandis, goji berry, chrysanthemum, and rose dried buds; beverages, including king sarsae, asia sarsae, diet s… Read more
Xiangxue Pharmaceutical (300147) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.069x
Based on the latest financial reports, Xiangxue Pharmaceutical (300147) has a cash flow conversion efficiency ratio of 0.069x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥75.64 Million) by net assets (CN¥1.10 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Xiangxue Pharmaceutical - Cash Flow Conversion Efficiency Trend (2007–2024)
This chart illustrates how Xiangxue Pharmaceutical's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Xiangxue Pharmaceutical Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Xiangxue Pharmaceutical ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
VOLEX PLC LS -25
F:64K
|
N/A |
|
Wetown Electric Group Co Ltd
SHG:688226
|
0.010x |
|
Konoike Transport Co. Ltd
F:2KT
|
N/A |
|
Dom Development S.A.
WAR:DOM
|
0.046x |
|
Mister Car Wash, Inc. Common Stock
NASDAQ:MCW
|
0.095x |
|
Dat Xanh Real Estate Service Contructions Corp
VN:DXG
|
0.008x |
|
Hainan Expressway Co Ltd
SHE:000886
|
-0.028x |
|
Eramet SA
PA:ERA
|
-0.104x |
Annual Cash Flow Conversion Efficiency for Xiangxue Pharmaceutical (2007–2024)
The table below shows the annual cash flow conversion efficiency of Xiangxue Pharmaceutical from 2007 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.44 Billion | CN¥18.17 Million | 0.013x | -88.91% |
| 2023-12-31 | CN¥2.31 Billion | CN¥263.44 Million | 0.114x | +41.15% |
| 2022-12-31 | CN¥2.82 Billion | CN¥227.38 Million | 0.081x | +17.71% |
| 2021-12-31 | CN¥3.76 Billion | CN¥257.56 Million | 0.069x | +13.35% |
| 2020-12-31 | CN¥4.25 Billion | CN¥257.18 Million | 0.060x | +199.49% |
| 2019-12-31 | CN¥4.11 Billion | CN¥83.02 Million | 0.020x | -11.21% |
| 2018-12-31 | CN¥4.01 Billion | CN¥91.24 Million | 0.023x | -19.37% |
| 2017-12-31 | CN¥3.88 Billion | CN¥109.53 Million | 0.028x | -47.65% |
| 2016-12-31 | CN¥3.68 Billion | CN¥198.48 Million | 0.054x | +19.47% |
| 2015-12-31 | CN¥3.55 Billion | CN¥159.89 Million | 0.045x | -49.04% |
| 2014-12-31 | CN¥1.87 Billion | CN¥165.58 Million | 0.088x | -53.92% |
| 2013-12-31 | CN¥1.71 Billion | CN¥328.37 Million | 0.192x | +148.14% |
| 2012-12-31 | CN¥1.54 Billion | CN¥118.91 Million | 0.077x | +271.56% |
| 2011-12-31 | CN¥1.42 Billion | CN¥29.55 Million | 0.021x | -37.21% |
| 2010-12-31 | CN¥1.37 Billion | CN¥45.47 Million | 0.033x | -75.75% |
| 2009-12-31 | CN¥337.62 Million | CN¥46.19 Million | 0.137x | -51.75% |
| 2008-12-31 | CN¥196.54 Million | CN¥55.72 Million | 0.284x | -60.67% |
| 2007-12-31 | CN¥191.45 Million | CN¥138.02 Million | 0.721x | -- |